Donate
Call the Lung HelpLine
Ask a Question
The following text field filters the results that follow as you type. Use Tab to access the results.
  1. Home
  2. Research & Reports
  3. About Our Research
  4. Meet the Researchers
  5. Xiaoyong Bao, PhD
Xiaoyong Bao, PhD

Xiaoyong Bao, PhD

University of Texas Medical Branch at Galveston

Research Project:
Targeting Protein That Regulates SARS-CoV-2 Could Lead to Better COVID-19 Treatments

Grant Awarded:

  • Emerging Respiratory Pathogen Award

Research Topics:

  • combination therapies experimental therapeutics
  • immunology immunotherapy
  • pathology

Research Diseases:

  • COVID-19
  • pneumonia
  • respiratory viruses

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in significant illness and death worldwide. New SARS-CoV-2 variants have been shown to evade vaccines and treatments that directly target viruses of the previous generation. This highlights the urgent need to discover therapeutic targets that can lead to effective treatments unaffected by virus mutations. We are researching the role of a protein called exchange protein directly activated by cAMP 1 (EPAC1), a novel host regulator of SARS-CoV-2 infection, in controlling replication of the virus and associated inflammation. The results of this project should provide valuable insights that can aid in developing novel treatments against SARS-CoV-2.

Page last updated: October 7, 2024

Implementation and Interpretation of Spirometry
Belgrade, MT | Dec 05, 2024 Freedom From Smoking Clinic
Manchester, CT | Jan 06, 2025
See All Events